The effect of RIG-I was also elucidated on paclitaxel resistance in NPC cells, whereby overexpression of RIG-I increased the sensitivity of NPC cells to paclitaxel and suppressed cancer progression [86]. This evidence concerns the gene RIGI and cancer.